isothiuronium has been researched along with Atrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, LW; Hsu, CM; Liu, CH | 1 |
1 other study(ies) available for isothiuronium and Atrophy
Article | Year |
---|---|
Nitric oxide synthase inhibitor ameliorates oral total parenteral nutrition-induced barrier dysfunction.
Topics: Administration, Oral; Animals; Atrophy; Bacterial Translocation; Dextrans; Enzyme Activation; Enzyme Inhibitors; Female; Fluorescein-5-isothiocyanate; Ileum; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Isothiuronium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Parenteral Nutrition, Total; Permeability; Rats; Rats, Sprague-Dawley; Solutions | 2000 |